An interview with the doctor behind the near-elimination of US deaths due to Rh disease.
A better understanding of the care and outcomes of women with severe morbidity who survive should provide insight into ways to improve care for all women and reduce both severe morbidity and mortality.
A study in Tehran tested this noninvasive intervention on women with uncomplicated pregnancies at full term.
In Florida, the public is worried and the news keeps getting worse.
For Contemporary OB/GYN, Dr Bobby Lazzara discusses key findings of a study published in Science Translational Medicine. The study looked at how delivery mode impacted the gut microbiome of infants and wondered about the long-term impact.
Pregnant women are worried, and their concern is warranted. Here is what we know now and what’s being done about this health crisis.
Clinicians should be aware of the potential for confounding of NIPT results by cfDNA released from a vanishing twin.
Antenatal anti-D immunoglobulin helps reduce the incidence of RhD alloimmunization in Rh-negative women, but should it be administered to non-sensitized women prophylactically?
Seven strategies to fight the rising tide.
A study in Sweden looked at safety and effectiveness.